13F HOLDINGS REPORT
Yiheng Capital Management, L.P.
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001420506-25-003340
Total Value
$678.1M
Positions
27
Other Managers
0
Confidential Omitted
No
Holdings (27)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ASTERA LABS INC | ALAB | 1,427,500 | $279.5M | 41.22% |
| 2 | NOAH HLDGS LTD | NOAH | 6,717,351 | $77.9M | 11.48% |
| 3 | JD.COM INC | JDCMF | 1,814,600 | $63.5M | 9.36% |
| 4 | BILIBILI INC | BLBLF | 1,418,564 | $39.8M | 5.88% |
| 5 | NEW ORIENTAL ED & TECHNOLOGY | 647581206 | 521,901 | $27.7M | 4.08% |
| 6 | JD.COM INC | JDCMF | 787,413 | $27.5M | 4.06% |
| 7 | VIASAT INC | VSAT | 735,500 | $21.6M | 3.18% |
| 8 | H WORLD GROUP LTD | HWLDF | 457,032 | $17.9M | 2.64% |
| 9 | INVENTIVA SA | IVEVF | 2,644,926 | $15.3M | 2.26% |
| 10 | ATRENEW INC | RERE | 3,163,117 | $14.6M | 2.15% |
| 11 | BILIBILI INC | BLBLF | 400,000 | $11.2M | 1.66% |
| 12 | ACM RESH INC | 00108J109 | 280,201 | $11.0M | 1.62% |
| 13 | VIRIDIAN THERAPEUTICS INC | VRDN | 500,261 | $10.8M | 1.59% |
| 14 | AKERO THERAPEUTICS INC | 00973Y108 | 191,076 | $9.1M | 1.34% |
| 15 | KYMERA THERAPEUTICS INC | KYMR | 122,605 | $6.9M | 1.02% |
| 16 | DENALI THERAPEUTICS INC | DNLI | 469,981 | $6.8M | 1.01% |
| 17 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 225,758 | $6.8M | 1.00% |
| 18 | DBV TECHNOLOGIES S A | DBVTF | 656,309 | $6.6M | 0.97% |
| 19 | SILVACO GROUP INC | SVCO | 1,096,282 | $5.9M | 0.87% |
| 20 | PONY AI INC | PYAIF | 200,300 | $4.5M | 0.66% |
| 21 | CELLEBRITE DI LTD | CLBT | 231,031 | $4.3M | 0.63% |
| 22 | TAL EDUCATION GROUP | TAL | 309,240 | $3.5M | 0.51% |
| 23 | AGORA INC | API | 533,547 | $2.0M | 0.30% |
| 24 | BEAM THERAPEUTICS INC | BEAM | 69,058 | $1.7M | 0.25% |
| 25 | YATSEN HLDG LTD | YSG | 96,328 | $872,732 | 0.13% |
| 26 | GENERATION BIO CO | 37148K209 | 105,524 | $645,807 | 0.10% |
| 27 | TUNIU CORP | TOUR | 314,437 | $299,438 | 0.04% |